NANOTECHNOLOGYMETAST (333797)

  https://cordis.europa.eu/project/id/333797

  FP7 (2007-2013)

  TREATING METASTATIC CANCER WITH NANOTECHNOLOGY

  Marie-Curie Action: "Career Integration Grants" (FP7-PEOPLE-2012-CIG)

  oncology  ·  nano-materials

  2013-04-01 Start Date (YY-MM-DD)

  2017-03-31 End Date (YY-MM-DD)

  € 100,000 Total Cost

  Description

Metastasis – the spread of cancer to distant organs, poses a great therapeutic challenge. Nanomaterials have many therapeutic advantages, such as the ability to target specific tissues and carry multiple drugs, making them promising candidates for treating metastasis. Despite the great need, there is a gap in the fundamental understanding what structural parameters can enhance the targeting capacity of nanomaterials to metastatic sites. This program is aimed at elucidating the mechanism by which therapeutic nanomaterials can be designed to target and treat metastatic cancer.

  Complicit Organisations

1 Israeli organisation participates in NANOTECHNOLOGYMETAST.